Meningioma 1 Antikörper
Kurzübersicht für Meningioma 1 Antikörper (ABIN7116478)
Target
Alle Meningioma 1 (MN1) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Aufreinigung
- Immunogen affinity purified
-
Reinheit
- ≥95 % as determined by SDS-PAGE
-
Immunogen
- meningioma(disrupted in balanced translocation) 1
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- IHC: 1:20-1:200
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
-
Haltbarkeit
- 12 months
-
-
- Meningioma 1 (MN1) (MN1 proto-oncogene (MN1))
-
Andere Bezeichnung
- MN1
-
Hintergrund
- Synonyms: Background:Transcriptional activator which specifically regulates expression of TBX22 in the posterior region of the developing palate. Required during later stages of palate development for growth and medial fusion of the palatal shelves. Promotes maturation and normal function of calvarial osteoblasts, including expression of the osteoclastogenic cytokine TNFSF11/RANKL. Necessary for normal development of the membranous bones of the skull(By similarity). May play a role in tumor suppression(Probable).
-
Gen-ID
- 4330
-
UniProt
- Q10571
Target
-